DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cerubidine (Daunorubicin) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cerubidine side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-30

Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-27

Valacyclovir Hydrochloride
    Dosage: 1 g, 1x/day
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Cerubidine
    Dosage: 60 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Vfend
    Dosage: unk
    Start date: 2011-10-17
    End date: 2011-12-07

Phenoxymethyl Penicillin
    Dosage: 3 millioniu, 1x/day
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Kidrolase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine



Possible Cerubidine side effects in male

Reported by a physician from France on 2012-05-25

Patient: male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vincristine
    Dosage: 2mg cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Phenoxymethyl Penicillin
    Dosage: 3iu6 per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-18
    End date: 2011-12-07

Nexium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-12-07

Vfend
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-12-07

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-27

Valacyclovir Hydrochloride
    Dosage: 1g per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-13
    End date: 2011-12-07

Kidrolase
    Dosage: 10iu3 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Cerubidine
    Dosage: 60mg cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine



Possible Cerubidine side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24

Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vfend
    Dosage: unk
    Start date: 2011-10-17
    End date: 2011-12-07

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Valacyclovir Hydrochloride
    Dosage: 1 g, 1x/day
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-27

Cerubidine
    Dosage: 60 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Phenoxymethyl Penicillin
    Dosage: 3 millioniu, 1x/day
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Kidrolase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Other drugs received by patient: Cyclophosphamide; Cytarabine; Methotrexate



Possible Cerubidine side effects in male

Reported by a physician from France on 2012-05-23

Patient: male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg per course
    Start date: 2011-10-27

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-10-20

Kidrolase
    Start date: 2011-10-24

Vfend
    Start date: 2011-10-17
    End date: 2011-11-27

Valacyclovir Hydrochloride
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-11-10

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-11-10

Vfend
    Start date: 2011-11-28
    End date: 2011-12-05

Dexamethasone
    Dosage: daily
    Administration route: Oral
    Start date: 2011-10-20
    End date: 2011-11-27

Phenoxymethyl Penicillin
    Dosage: 3 000 000 iu
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Kidrolase
    Start date: 2011-10-27

Kidrolase
    Start date: 2011-11-16

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-11-03

Nexium
    Dosage: daily
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-11-03

Kidrolase
    Start date: 2011-11-10

Kidrolase
    Start date: 2011-11-13

Kidrolase
    Start date: 2011-11-06

Nexium
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Vfend
    Start date: 2011-12-06
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-10-20

Kidrolase
    Start date: 2011-10-30

Kidrolase
    Start date: 2011-11-03

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-10-27

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017